Endo International Ordinary Shares reported $176.86M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Aerie Pharmaceuticals AERI:US USD 6.93M 3.19M
Amarin AMRN:US USD 23.94M 11.87M
Ani Pharmaceuticals ANIP:US USD 32.89M 2.4M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Coherus Biosciences CHRS:US USD 35.23M 23.96M
Eli Lilly And LLY:US USD 1.58B 148.6M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Hikma Pharmaceutical HIK:LN USD 590M 62M
Horizon Pharma HZNP:US USD 234.13M 3.92M
Lannett LCI:US USD 62.48M 3.85M
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
Merk MRK:US USD 3.43B 715M
Novartis NOVN:VX USD 3.66B 92M
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Patterson Companies PDCO:US USD 1.21B 79.4M
Perrigo Ordinary Shares PRGO:US USD 737.3M 12.3M
Pfizer PFE:US USD 6.09B 2.58B
Phibro Animal Health PAHC:US USD 163.88M 12.97M
Revance Therapeutics RVNC:US USD 10.74M 1.21M
Supernus Pharmaceuticals SUPN:US USD 25.88M 5.42M
Takeda 4502:JP JPY 305.44B 12.56B
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Xeris Pharmaceuticals Inc XERS:US USD 5.26M 450K
Zoetis ZTS:US USD 606M 14M